Literature DB >> 11391319

The association of Apgar score with subsequent death and cerebral palsy: A population-based study in term infants.

D Moster1, R T Lie, L M Irgens, T Bjerkedal, T Markestad.   

Abstract

OBJECTIVE: To estimate the risk of adverse outcomes for newborns with a low Apgar score. STUDY
DESIGN: Population-based cohort study. All 235,165 children born between 1983 and 1987 in Norway with a birth weight of at least 2500 g and no registered birth defects were followed up from birth to age 8 to 12 years by linkage of 3 national registries. Outcomes were death and cerebral palsy (CP).
RESULTS: Five-minute Apgar scores of 0 to 3 were recorded for 0.1%, and scores of 4 to 6 were recorded for 0.6% of the children. Compared with children who had 5-minute Apgar scores of 7 to 10, children who had scores of 0 to 3 had a 386-fold increased risk for neonatal death (95% CI: 270-552) and an 81-fold (48-138) increased risk for CP. If Apgar scores at both 1 and 5 minutes were 0 to 3, the risks for neonatal death and CP were increased 642-fold (442-934) and 145-fold (85-248), respectively, compared with scores of 7 to 10.
CONCLUSION: The strong association of low Apgar scores with death and CP in this population with a low occurrence of low scores shows that the Apgar score remains important for the early identification of infants at increased risk for serious and fatal conditions.

Entities:  

Mesh:

Year:  2001        PMID: 11391319     DOI: 10.1067/mpd.2001.114694

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  57 in total

Review 1.  Cerebral palsy--medicolegal aspects.

Authors:  I Blumenthal
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

2.  Childhood outcomes following preterm prelabor rupture of the membranes (PPROM): a population-based record linkage cohort study.

Authors:  C L Roberts; P Wagland; S Torvaldsen; J R Bowen; J P Bentley; J M Morris
Journal:  J Perinatol       Date:  2017-08-03       Impact factor: 2.521

3.  Substance use of pregnant women and early neonatal morbidity: where to focus intervention?

Authors:  Igor Burstyn; Nitin Kapur; Nicola M Cherry
Journal:  Can J Public Health       Date:  2010 Mar-Apr

4.  Joint association of Apgar scores and early neonatal symptoms with minor disabilities at school age.

Authors:  D Moster; R T Lie; T Markestad
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-01       Impact factor: 5.747

5.  Developmental trajectories of children with birth asphyxia through 36 months of age in low/low-middle income countries.

Authors:  Jan L Wallander; Carla Bann; Elwyn Chomba; Shivaprasad S Goudar; Omrana Pasha; Fred J Biasini; Elizabeth M McClure; Vanessa Thorsten; Dennis Wallace; Waldemar A Carlo
Journal:  Early Hum Dev       Date:  2014-05-09       Impact factor: 2.079

6.  Perinatal factors reported by mothers: do they agree with medical records?

Authors:  Pénélope Troude; Laurence Foix L'Hélias; Anne-Marie Raison-Boulley; Christine Castel; Christine Pichon; Jean Bouyer; Elise de La Rochebrochard
Journal:  Eur J Epidemiol       Date:  2008-06-17       Impact factor: 8.082

7.  Association of Apgar scores with death and neurologic disability.

Authors:  Vera Ehrenstein
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

8.  Association of cerebral palsy with Apgar score in low and normal birthweight infants: population based cohort study.

Authors:  Kari Kveim Lie; Else-Karin Grøholt; Anne Eskild
Journal:  BMJ       Date:  2010-10-06

9.  Neurodevelopmental Disorders or Early Death in Siblings of Children With Cerebral Palsy.

Authors:  Mette C Tollånes; Allen J Wilcox; Camilla Stoltenberg; Rolv T Lie; Dag Moster
Journal:  Pediatrics       Date:  2016-08       Impact factor: 7.124

10.  Outcome of term infants using apgar scores at 10 minutes following hypoxic-ischemic encephalopathy.

Authors:  Abbot R Laptook; Seetha Shankaran; Namasivayam Ambalavanan; Waldemar A Carlo; Scott A McDonald; Rosemary D Higgins; Abhik Das
Journal:  Pediatrics       Date:  2009-12       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.